Common TitleALLY-1
Official Title Daclatasvir with Sofosbuvir and Ribavirin for Hepatitis C Virus Infection with Advanced Cirrhosis or Post-Liver Transplantation Recurrence
Phase Phase III
ClinicalTrials.gov NCT02032875
Treatments
Daclatasvir
Daclatasvir
Tradename:DaklinzaOther Names:DCVClass:DiscontinuedFunding
IndustryBristol-Myers Squibb